EE176 Hospitalization Trends for All Intestinal Infectious Diseases Since Introduction of Rotavirus Gastroenteritis (RVGE) Vaccine in Ireland

Aileen Murphy; Ann Kirby; Federica De Blasio

doi:10.1016/j.jval.2023.09.445

EE176 Hospitalization Trends for All Intestinal Infectious Diseases Since Introduction of Rotavirus Gastroenteritis (RVGE) Vaccine in Ireland

Aileen Murphy
, Ann Kirby
, Federica De Blasio

Cork University Business School

Research output: Contribution to journal › Meeting abstract › peer-review

Abstract

Since the introduction of the Rotavirus gastroenteritis (RVGE) vaccine on the Irish national immunisation programme in 2016 almost 2,000 RVGE hospitalisations have been avoided with a direct economic impact of €3.7 million between December 2016 and November 2020 (Murphy et al 2023). National inpatient data shows prior to this RVGE accounted for 16% of all intestinal infectious diseases amongst children under 5. However, such data can be subject to misclassification or miscoding leaning towards underreporting. Therefore this paper examines hospitalisation trends for all intestinal infectious diseases (ICD-10-AM A00-A09) and the associated economic impact since the introduction of the RVGE vaccine amongst children under 5 in Ireland.

Original language	English
Journal	Value in Health
Volume	26
Issue number	12
DOIs	https://doi.org/10.1016/j.jval.2023.09.445
Publication status	Published - Dec 2023
Event	ISPOR Europe 2023 - Copenhagen, Denmark Duration: 12 Nov 2023 → 15 Nov 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Rotavirus gastroenteritis
Acute gastroenteritis
Irish
Rotavirus
Rotavirus vaccine
Medicine
Rotavirus Infections
Pediatrics
Virology
Virus
Linguistics
Philosophy

Access to Document

10.1016/j.jval.2023.09.445

Cite this

@article{0ef0e5ae1d42486f80c232f95fd663f9,

title = "EE176 Hospitalization Trends for All Intestinal Infectious Diseases Since Introduction of Rotavirus Gastroenteritis (RVGE) Vaccine in Ireland",

abstract = "Since the introduction of the Rotavirus gastroenteritis (RVGE) vaccine on the Irish national immunisation programme in 2016 almost 2,000 RVGE hospitalisations have been avoided with a direct economic impact of €3.7 million between December 2016 and November 2020 (Murphy et al 2023). National inpatient data shows prior to this RVGE accounted for 16\% of all intestinal infectious diseases amongst children under 5. However, such data can be subject to misclassification or miscoding leaning towards underreporting. Therefore this paper examines hospitalisation trends for all intestinal infectious diseases (ICD-10-AM A00-A09) and the associated economic impact since the introduction of the RVGE vaccine amongst children under 5 in Ireland.",

keywords = "Rotavirus gastroenteritis, Acute gastroenteritis, Irish, Rotavirus, Rotavirus vaccine, Medicine, Rotavirus Infections, Pediatrics, Virology, Virus, Linguistics, Philosophy",

author = "Aileen Murphy and Ann Kirby and \{De Blasio\}, Federica",

year = "2023",

month = dec,

doi = "10.1016/j.jval.2023.09.445",

language = "English",

volume = "26",

journal = "Value in Health",

issn = "1098-3015",

publisher = "Elsevier Ltd",

number = "12",

note = "ISPOR Europe 2023 ; Conference date: 12-11-2023 Through 15-11-2023",

}

TY - JOUR

T1 - EE176 Hospitalization Trends for All Intestinal Infectious Diseases Since Introduction of Rotavirus Gastroenteritis (RVGE) Vaccine in Ireland

AU - Murphy, Aileen

AU - Kirby, Ann

AU - De Blasio, Federica

PY - 2023/12

Y1 - 2023/12

N2 - Since the introduction of the Rotavirus gastroenteritis (RVGE) vaccine on the Irish national immunisation programme in 2016 almost 2,000 RVGE hospitalisations have been avoided with a direct economic impact of €3.7 million between December 2016 and November 2020 (Murphy et al 2023). National inpatient data shows prior to this RVGE accounted for 16% of all intestinal infectious diseases amongst children under 5. However, such data can be subject to misclassification or miscoding leaning towards underreporting. Therefore this paper examines hospitalisation trends for all intestinal infectious diseases (ICD-10-AM A00-A09) and the associated economic impact since the introduction of the RVGE vaccine amongst children under 5 in Ireland.

AB - Since the introduction of the Rotavirus gastroenteritis (RVGE) vaccine on the Irish national immunisation programme in 2016 almost 2,000 RVGE hospitalisations have been avoided with a direct economic impact of €3.7 million between December 2016 and November 2020 (Murphy et al 2023). National inpatient data shows prior to this RVGE accounted for 16% of all intestinal infectious diseases amongst children under 5. However, such data can be subject to misclassification or miscoding leaning towards underreporting. Therefore this paper examines hospitalisation trends for all intestinal infectious diseases (ICD-10-AM A00-A09) and the associated economic impact since the introduction of the RVGE vaccine amongst children under 5 in Ireland.

KW - Rotavirus gastroenteritis

KW - Acute gastroenteritis

KW - Irish

KW - Rotavirus

KW - Rotavirus vaccine

KW - Medicine

KW - Rotavirus Infections

KW - Pediatrics

KW - Virology

KW - Virus

KW - Linguistics

KW - Philosophy

UR - https://openalex.org/W4390146157

U2 - 10.1016/j.jval.2023.09.445

DO - 10.1016/j.jval.2023.09.445

M3 - Meeting abstract

SN - 1098-3015

VL - 26

JO - Value in Health

JF - Value in Health

IS - 12

T2 - ISPOR Europe 2023

Y2 - 12 November 2023 through 15 November 2023

ER -

EE176 Hospitalization Trends for All Intestinal Infectious Diseases Since Introduction of Rotavirus Gastroenteritis (RVGE) Vaccine in Ireland

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this